Trial intelligence / Profile preview

Low-dose Dexamethasone in Total Knee Arthroplasty

NCT01612702Phase 4Completed

Start
Apr 2011
Primary completion
Dec 2011
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 4, randomised, open-label trial of dexamethasone in postoperative nausea and vomiting (PONV) and postoperative pain (2 arms). Primary endpoint: Incidence of Nausea and Vomiting at 72 hours. Started Apr 2011; status: completed.

02

Drugs

dexamethasone
03

Conditions

postoperative nausea and vomiting (PONV)postoperative pain

Beyond the preview

Go deeper on NCT01612702.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01612702.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call